Arbeiten in der Schweiz

Lead strategy development & definition for the Biosimilars Business Unit Lead strategic planning process within the Biosimilars Business Unit in close collaboration with the Leadership Team and Fresenius Kabi headquarters. Prepare and lead strategy and business update presentations to the Leadership team and any other governance bodies. Actively monitor changes in the biosimilars business. Search for benchmarks within and at the periphery of the biosimilars industry; Think strategically and critically about the impact for the biosimilars industry in general and Biosimilars Business Unit in particular; Drive the strategic agenda at the Leadership Team, ensure it is thinking beyond the day-to-day business; Define & lead the tracking of the Biosimilars Business Unit long-term strategy implementation plan Lead active biosimilars portfolio management activities Strategic alignment between the vision, commercial capabilities, therapeutic areas alignment, manufacturing and supply chain capabilities, development capabilities, etc.; Commercial viability, including market and competitive dynamics; Technical (clinical, regulatory, market access, CMC...) and execution risks (proper resources allocation, compliance risk, dependency risk based on partners/3 rd parties...), along with mitigation options; Risk/reward profile of the portfolio. Lead the exploration of new targets for biosimilars while maintaining a holistic overview of the target portfolio, including assessment of strategic alignment, commercial viability & risk management; Develop, implement and nurture a cross -Biosimilars Business Unit idea generation culture, in collaboration with Corporate's efforts; Co-lead in collaboration with the Commercial and Project Leadership Management teams the review of existing life-cycle management opportunities and the prioritization of potential new ones; Co-lead in collaboration with the Business Development team the prioritization of in-licensing options to compliment, accelerate or de-risk the portfolio. Lead strategic fitness checks including strategy implementation roadmap definition Deliver to the Leadership team quarterly cross-functional fitness checks: Leading indicators: monitor external factors and influencers shaping the biosimilars industry Competitive mapping: monitor progresses of key competitors within biosimilars space Strategic Roadmap: define & coordinate the tracking of a rolling quarter-by-quarter 1-year strategy implementation roadmap in line with the long-term Biosimilars Business Unit strategy Drive strategic initiatives Advance the execution of the Biosimilars Business Unit strategy by leading or co-leading strategic initiatives: e.g. regional strategy, evolution of the business model, development strategy, laboratory strategy, etc. Support Biosimilars Business Unit Ambition Support and actively participate in transformational initiatives: e.g. internal/external communication of strategic ambition, culture, etc.; Advises and challenges forecasting activities at the product-level; Advises and challenges assessment of competitive intelligence, interlinks between individual data points; Advise on M&A opportunities Act as catalyst for cross-functional collaboration Act as role model for cross-functional collaboration within the Biosimilars Business Unit; Maintain high level of exposure to key Fresenius Kabi stakeholders outside the Biosimilars Business Unit.